| Name | Title | Contact Details |
|---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Bramalea Denistry is a Brampton, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Workplace Health, Starts with a Smile
PhotoMedex is a leader in the dermatology market, committed to the Science of Skin Health in disease management and skin rejuvenation. We focus our efforts where we can make meaningful differences in dermatological applications for psoriasis and vitiligo, therapeutic skin care and LED therapy for acne and photodamage. Our Purpose, to provide branded dermatological solutions of superior value to improve patients` lives now and into the future, is our common goal and leads our thinking. The results of which will be realized in physicians and patients rewarding us with winning sales, profit and equity generation. Our commitment to safety and efficacy is reflected in our dedication to scientific development and has led to a broad range of FDA clearances. XTRAC was the first FDA market-cleared excimer laser system for the treatment of dermatological applications, including psoriasis and vitiligo. The Omnilux LED system carries FDA clearances for skin rejuvenation, acne and pain management. Neova, the science of skin care, holds dozens of patents on its clinically proven Copper Peptide technology for skin health, hair care and wound care.
SAINT MARYS REGIONAL MEDICAL CENTER is a Lewiston, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.